CPOINT Capital Corp. Announces Changes to Holdings in Conavi Medical Corp.

TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- CPOINT Capital Corp. (“CPOINT”) announces that, on April 23, 2025, it and its affiliate Juno Pharmaceuticals LP (“Juno”) acquired 1,875,000 common shares (the “Common Shares”) in the capital of Conavi Medical Corp. (the “Company”) (625,000 of which are held by CPOINT and 1,250,000 of which are held by Juno), in connection with a public offering of the Company by way of a short form prospectus dated April 15, 2025. CPOINT and its affiliate Juno purchased the Common Shares at a price of $0.40 per Common Share for total consideration of $750,000.